In this new Trade To Black podcast, TDR Founder Shadd Dales and contributor Anthony Varrell interview the founder of Apeiron Investment Group, Christian Angermayer. Aperion is best known for deep ...
Atai Life Sciences Investor Christian Angermayer Addresses Recent Trial Results And Pipeline Outlook
In our latest Trade To Black Podcast, TDR Founder Shadd Dales and lead financial writer Benjamin A. Smith interview the founder of Apeiron Investment Group, Christian Angermayer. Aperion has deep a ...
NEW YORK and AMSTERDAM, July 01, 2025 (GLOBE NEWSWIRE) -- atai Life Sciences (ATAI) (NASDAQ: ATAI) (“atai”), a clinical-stage biopharmaceutical company on a mission to develop highly effective mental ...
NEW YORK & LONDON & BERLIN--(BUSINESS WIRE)--ATAI Life Sciences, the global biotech platform dedicated to curing mental health disorders, has completed its series B financing round of $43 million (EUR ...
June 11 (Reuters) - Atai Life Sciences B.V., backed by billionaire investor Peter Thiel, said on Friday it was looking to raise as much as $214.3 million through a U.S. initial public offering, ...
n a suite on the fourth floor of the Four Seasons in Austin, Texas, the German billionaire Christian Angermayer is talking about his newest investment: the Enhanced Games, a 21st-century Olympics on ...
ATAI Life Sciences is topping off a busy year with a $125 million financing, which will support the preclinical and clinical development for its mental health pipeline, including programs in opioid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results